Ra Medical Systems to Host Webcast Discussing the Role of Excimer Lasers in the Treatment of Psoriasis during the Pandemic
11 November 2020 - 12:50PM
Business Wire
Webcast to feature Theodore J. Daly, MD, FAAD,
FSPD, FASD, 33-year dermatology veteran with more than 20 years of
experience using excimer lasers
Ra Medical Systems, Inc. (NYSE: RMED) is hosting a webcast, The
Inimitable Role of Excimer Lasers During the COVID-19 Pandemic,
featuring Theodore J. Daly, MD, FAAD, FSPD, FASD, Director of
Garden City Dermatology, discussing the use of excimer lasers such
as the Pharos excimer laser system for the treatment of psoriasis
during the pandemic.
Presentation topics will include:
- Reviewing American Academy of Dermatology (AAD) guidance on the
use of immunosuppressive agents during COVID
- Discussing the impact on day-to-day clinical practice and
individual patient treatment regimens
- Exploring alternative treatment modalities, including excimer
lasers
Date:
Wednesday, December 2, 2020
Time:
7:00-8:00 p.m. Eastern time
Pre-registration:
Here
If you are unable to attend the live event, an archived webcast
will be available on the Events section of the Ra Medical website
here.
Theodore J. Daly, MD, a triple board certified
dermatologist, has practiced at Garden City Dermatology for more
than 33 years and a staff member at the Icahn School of Medicine at
Mt. Sinai. He focuses on the treatment of psoriasis and has used
excimer lasers for more than 20 years. Dr. Daly trained at
Jefferson Medical College, Harvard-Brigham and Women's Hospital and
the University of Colorado School of Medicine. He has authored
numerous publications and has been featured on the Today Show and
Fox and Friends, and in interviews on CNN and MSNBC among
others.
About Ra Medical Systems
Ra Medical Systems commercializes excimer lasers and catheters
for the treatment of vascular and dermatological diseases. In May
2017 the DABRA excimer laser system received FDA 510(k) clearance
in the U.S. for crossing chronic total occlusions, or CTOs, in
patients with symptomatic infrainguinal lower extremity vascular
disease with an intended use for ablating a channel in occlusive
peripheral vascular disease. The Pharos excimer laser system is
FDA-cleared and is used as a tool in the treatment of psoriasis,
vitiligo, atopic dermatitis and leukoderma. DABRA and Pharos are
both based on Ra Medical’s core excimer laser technology platform
and deploy similar mechanisms of action. Ra Medical manufactures
DABRA and Pharos excimer lasers and catheters in a
32,000-square-foot facility located in Carlsbad, Calif. The
vertically integrated facility is ISO 13485 certified and is
licensed by the State of California to manufacture sterile,
single-use catheters in controlled environments.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201111005275/en/
At the Company: Jeffrey Kraws President, Ra Medical
Systems 760-496-9008 jkraws@ramed.com
Investors: LHA Investor Relations Jody Cain 310-691-7100
jcain@lhai.com
Ra Medical Systems (NYSE:RMED)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Ra Medical Systems (NYSE:RMED)
Historical Stock Chart
Von Apr 2023 bis Apr 2024